MX9300553A - ANTIBIOTIC COMPOUNDS. - Google Patents

ANTIBIOTIC COMPOUNDS.

Info

Publication number
MX9300553A
MX9300553A MX9300553A MX9300553A MX9300553A MX 9300553 A MX9300553 A MX 9300553A MX 9300553 A MX9300553 A MX 9300553A MX 9300553 A MX9300553 A MX 9300553A MX 9300553 A MX9300553 A MX 9300553A
Authority
MX
Mexico
Prior art keywords
antibiotics
preparation
treatment
antibiotic compounds
compounds
Prior art date
Application number
MX9300553A
Other languages
Spanish (es)
Inventor
Michael John Betts
Gareth Morse Davies
Michael Lingard Swain
Original Assignee
Zeneca Limited Y Zeneca Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929202298A external-priority patent/GB9202298D0/en
Application filed by Zeneca Limited Y Zeneca Pharma filed Critical Zeneca Limited Y Zeneca Pharma
Publication of MX9300553A publication Critical patent/MX9300553A/en

Links

Abstract

La presente invención se refiere a los carbapems y se proporciona un compuesto que contienen al grupo de fenilo substituído oncarboxi. La invención además se refiere a los procedimientos para su preparación, a los compuestos intermedios para su preparación, a su uso como agentes terapéuticos, y a las composiciones farmacéuticas que contienen a los mismos. Los compuestos de la invención son antibióticos, y se pueden usar para el tratamiento de cualquier enfermedad que está tratada convencionalmente con los antibióticos, por ejemplo, en el tratamiento de infecciones bacteriales, en mamíferos, incluyendo a los humanos.The present invention relates to carbapems and a compound containing the oncarboxy substituted phenyl group is provided. The invention further relates to processes for their preparation, to intermediates for their preparation, to their use as therapeutic agents, and to pharmaceutical compositions containing the same. The compounds of the invention are antibiotics, and can be used for the treatment of any disease that is conventionally treated with antibiotics, for example, in the treatment of bacterial infections, in mammals, including humans.

MX9300553A 1992-02-04 1993-02-02 ANTIBIOTIC COMPOUNDS. MX9300553A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929202298A GB9202298D0 (en) 1992-02-04 1992-02-04 Antibiotic compounds
GB939300456A GB9300456D0 (en) 1992-02-04 1993-01-12 Antibiotic compounds

Publications (1)

Publication Number Publication Date
MX9300553A true MX9300553A (en) 1993-09-01

Family

ID=26300260

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9300553A MX9300553A (en) 1992-02-04 1993-02-02 ANTIBIOTIC COMPOUNDS.

Country Status (1)

Country Link
MX (1) MX9300553A (en)

Similar Documents

Publication Publication Date Title
CO4970821A1 (en) NEW MACROLIDES
ES2170141T3 (en) 4-AMINODERIVATES OF MYCOPHENOLIC ACID WITH IMMUNOSUPPRESSING ACTIVITY.
PA8524501A1 (en) MACROLID ANTIBIOTICS
HN1998000074A (en) DERIVATIVES FROM MACROLIDES C-4 SUBSTITUTED
ES2181725T3 (en) HIV PROTEASA INHIBITORS.
PA8485601A1 (en) AZALIDAS OF 13 MEMBERS AND THEIR USE AS ANTIBIOTIC AGENTS.
ES2164717T3 (en) SULFONAMIDE TRICICLIC COMPOUNDS USEFUL TO INHIBIT THE FUNCTION OF G-PROTEIN AND FOR THE TREATMENT OF PROLIFERATIVE DISEASES.
PA8432901A1 (en) PIRIDILPIRROL COMPOUNDS
PA8465901A1 (en) NEW DERIVATIVES OF ERYTHROMYCIN
GT199900192A (en) NEW MACROLID ANTIBIOTICS.
SE7611103L (en) PROCEDURE FOR PREPARING 2-AZETIDINONE COMPOUNDS
AR005642A1 (en) ANTIBIOTIC COMPOUNDS OF CEPHALOSPORIN, USE OF THE SAME TO PREPARE PHARMACEUTICAL COMPOSITIONS, SUCH PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM, INTERMEDIATE COMPOUNDS OF APPLICATION IN THE PREPARATION OF THE FIRST INTERESTS AND PREPARATION OF SUCH COMPOSITIONS
AR001931A1 (en) 7-acylamino-3-iminomethyl (substituted) cephalosporin compound a process for its production intermediates in its production a pharmaceutical composition containing such compounds its use as pharmaceutical compounds and a method of treating microbial diseases by administration of such compounds
ES2174921T3 (en) HIV PROTEASE INHIBITORS.
AR030540A1 (en) ANTIPICORNAVIRAL COMPOUNDS AND COMPOSITIONS, THEIR PHARMACEUTICAL USE, AND MATERIALS FOR SYNTHESIS
ES2177811T3 (en) USE OF NITROFLAVONOIDS FOR THE TREATMENT OF ANXIETY.
ES2144154T3 (en) DERIVATIVES OF ERYTHROMYCIN A 9-0-OXIME GIVEN WITH ANTIBIOTIC ACTIVITY.
AR025379A1 (en) 9A-AZALIDAS WITH ANTIBACTERIAL ACTIVITY.
EA200001029A1 (en) HYGROMYCIN DERIVATIVES
MX9300553A (en) ANTIBIOTIC COMPOUNDS.
BR9611276A (en) Compound pharmaceutical formulation process for treatment or prophylaxis of diseases or conditions of humans and use of a compound
AR004484A1 (en) NEW 1,2,3,4-TETRAHIDRO-2-NAFTALENAMINAS FENILO-SUBSTITUTED IN THE AROMATIC RING, ITS PREPARATION, ITS THERAPEUTIC APPLICATIONS AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
RU94019991A (en) Antibiotic composition
CO4410328A1 (en) COMPOUNDS WHICH ARE DERIVATIVE FROM THE ANTIBIOTICS MACROLIDES ROSARAMYCIN, REPROMYCIN, 5-MICAMINOSYLTILONOLIDE, DESMYCO-SINE, LACTENOCINE, O-DESMETIL-LACTENOCINE, CIRRAMYCIN A1, AND 23-DEOXYMICAMINOSYLTILONOLIDE
MX9302578A (en) ANTIVIRAL AGENTS.

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status

Owner name: NOVO NORDISK HEALTH CARE AG

PD Change of proprietorship

Owner name: ASTRAZENECA UK LIMITED